Omega-3 fatty acids for the management of hypertriglyceridemia: a science advisory from the American Heart Association
AC Skulas-Ray, PWF Wilson, WS Harris, EA Brinton… - Circulation, 2019 - Am Heart Assoc
Hypertriglyceridemia (triglycerides 200–499 mg/dL) is relatively common in the United
States, whereas more severe triglyceride elevations (very high triglycerides,≥ 500 mg/dL) …
States, whereas more severe triglyceride elevations (very high triglycerides,≥ 500 mg/dL) …
Polyunsaturated fatty acids and recurrent mood disorders: phenomenology, mechanisms, and clinical application
E Messamore, DM Almeida, RJ Jandacek… - Progress in lipid …, 2017 - Elsevier
A body of evidence has implicated dietary deficiency in omega-3 polyunsaturated fatty acids
(n-3 PUFA), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), in …
(n-3 PUFA), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), in …
A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: Results from a 16 week …
DG Robinson, JA Gallego, M John, LA Hanna… - Schizophrenia …, 2019 - Elsevier
Omega-3 treatment studies for multi-episode schizophrenia or clinical high risk for
conversion to psychosis states have had variable, and often negative, results. To examine …
conversion to psychosis states have had variable, and often negative, results. To examine …
Detection and treatment of omega-3 fatty acid deficiency in psychiatric practice: Rationale and implementation
E Messamore, RK McNamara - Lipids in health and disease, 2016 - Springer
A body of translational evidence has implicated dietary deficiency in long-chain omega-3
(LC n-3) fatty acids, including eicosapenaenoic acid (EPA) and docosahexaenoic acid …
(LC n-3) fatty acids, including eicosapenaenoic acid (EPA) and docosahexaenoic acid …
Omega-3 fatty acids as druggable therapeutics for neurodegenerative disorders
Neurodegenerative disorders are commonly associated with a complex pattern of
pathophysiological hallmarks, including increased oxidative stress and neuroinflammation …
pathophysiological hallmarks, including increased oxidative stress and neuroinflammation …
Omega-3 fatty acids reduce cardiometabolic risk in first-episode schizophrenia patients treated with antipsychotics: findings from the OFFER randomized controlled …
T Pawełczyk, M Grancow-Grabka, N Żurner… - Schizophrenia …, 2021 - Elsevier
Metabolic syndrome (MetS) increases the risk of premature mortality observed in
schizophrenia (SCZ). N− 3 polyunsaturated fatty acid (PUFA) deficiency has been reported …
schizophrenia (SCZ). N− 3 polyunsaturated fatty acid (PUFA) deficiency has been reported …
Cardiometabolic risks and omega‐3 index in recent‐onset bipolar I disorder
LR Wulsin, TJ Blom, M Durling, JA Welge… - Bipolar …, 2018 - Wiley Online Library
Objectives The aims of the present study were to characterize cardiometabolic risk factors in
a cohort of bipolar disorder patients with limited exposure to psychotropic medications, and …
a cohort of bipolar disorder patients with limited exposure to psychotropic medications, and …
Investigating Metabolomic and Transcriptomic Signatures of Metabolic Dysfunction in Antipsychotic-naïve Patients
J Lee - 2022 - search.proquest.com
Psychosis spectrum disorders (PSDs) are characterized by metabolic dysfunction, arising
from intrinsic and external factors, including antipsychotic (AP) treatment. Transcriptomics …
from intrinsic and external factors, including antipsychotic (AP) treatment. Transcriptomics …